Celebrex and Vioxx, two fast selling anti-inflammatory drugs have recently been linked to an increased risk of heart attacks, strokes and other cardiovascular events, according to various news reports.
While some sources have disputed the claims of increased risks, an article from the National Post asks if those risks are really worth it to consumers.
Celebrex and Vioxx are known as Cox-2 inhibitors. They reportedly act by controlling painful inflammation, similar to the effects of aspirin. However, some research reports have found that Cox-2 inhibitors result in fewer ulcers than painkillers such as aspirin. The pills soon became dubbed by some as “Super-Aspirin.”
Fewer ulcers than aspirin may sound like a good thing except that new research is finding these drugs may have a more serious side effect: an increased risk of heart attack. To make matters worse, millions of the same people that suffer from arthritis also suffer from heart disease. This leads us to the question… Are you taking chances with drugs?
While drug manufacturers dispute the results of recent research, other news about these Cox-2 inhibitors has also surfaced. According to an article in the National Post, the makers of Celebrex have been criticized “for releasing only half its clinical trial data on the drug for publication.” When researchers looked at the longer-term data the drug was found not to be any more effective at preventing ulcers than painkillers costing a fraction of its price.
One could conclude that taking these drugs may potentially increase ones risk of ulcers, heart attacks, strokes and other cardiovascular events. Is it worth the risk?
Source: The National Post / Why should I take chances?
planetc1.com-news @ 5:23 am | Article ID: 1000124589